Sotrastaurin

N/A

Report date: 2024/05/22 20:00:38
NME

Base Information

Drug NameSotrastaurin
Drug Alias Name索曲妥林Sotrastaurin acetatesotrastaurina索曲滔林sotrastaurine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitorsImmunosuppressants
TargetsProtein kinase C
Therapy Area/IndicationsUveal melanomaPlaque psoriasisRejection of renal transplantation +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[30] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgColumbia University
Active IndicationsN/A
Inactive IndicationsUveal melanomaPlaque psoriasisRejection of renal transplantation +[13] 

Other Information

ATC CodeN/A
Related LinksKEGG